Cargando…
Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units
Background: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to antibiotics in the NICU is highly desirable, particularly through benchmarking methods. Methods: Description of aminoglycosides prescriptions in 23 French NICU using the same...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614949/ https://www.ncbi.nlm.nih.gov/pubmed/34827360 http://dx.doi.org/10.3390/antibiotics10111422 |
_version_ | 1784603985313792000 |
---|---|
author | Martin-Mons, Séverine Gouyon, Béatrice Lorrain, Séverine Abasse, Soumeth Alexandre, Cénéric Binson, Guillaume Brat, Roselyne Caeymaex, Laurence Couringa, Yvan Desbruyeres, Cécile Meglio, Marine Dorsi-Di Escourrou, Guillaume Flamein, Florence Flechelles, Olivier Girard, Olivier Kermorvant-Duchemin, Elsa Lapillonne, Alexandre Lafon, Catherine Di Maio, Massimo Mazeiras, Gaël Mourdie, Julien Moussy-Durandy, Amélie Pages, Anne-Sophie Ramful, Duksha Razafimahefa, Hasinirina Rosenthal, Jean-Marc Iacobelli, Silvia Gouyon, Jean-Bernard |
author_facet | Martin-Mons, Séverine Gouyon, Béatrice Lorrain, Séverine Abasse, Soumeth Alexandre, Cénéric Binson, Guillaume Brat, Roselyne Caeymaex, Laurence Couringa, Yvan Desbruyeres, Cécile Meglio, Marine Dorsi-Di Escourrou, Guillaume Flamein, Florence Flechelles, Olivier Girard, Olivier Kermorvant-Duchemin, Elsa Lapillonne, Alexandre Lafon, Catherine Di Maio, Massimo Mazeiras, Gaël Mourdie, Julien Moussy-Durandy, Amélie Pages, Anne-Sophie Ramful, Duksha Razafimahefa, Hasinirina Rosenthal, Jean-Marc Iacobelli, Silvia Gouyon, Jean-Bernard |
author_sort | Martin-Mons, Séverine |
collection | PubMed |
description | Background: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to antibiotics in the NICU is highly desirable, particularly through benchmarking methods. Methods: Description of aminoglycosides prescriptions in 23 French NICU using the same computerized system over a 4-year period (2017–2020). A benchmarking program of antibiotics prescription was associated. Results: The population included 53,818 patients. Exposition rates to gentamicin and amikacin were 31.7% (n = 17,049) and 9.1% (n = 4894), respectively. Among neonates exposed to gentamicin, 90.4% of gentamicin and 77.6% of amikacin treatments were started within the 1st week of life. Among neonates exposed to amikacin, 77.6% started amikacin within the 1st week. The average daily dose of gentamicin at first prescription increased over the study period from 3.9 in 2017 to 4.4 mg/kg/d in 2020 (p < 0.0001). Conversely, the corresponding amikacin daily doses decreased from 13.0 in 2017 to 12.3 mg/kg/d in 2020 (p = 0.001). The time interval between the first 2 doses of gentamicin was mainly distributed in 3 values during the first week of life: 49.4% at 24 h, 26.4% at 36 h, and 22.9% at 48 h. At first amikacin prescription, the time interval was distributed in 4 categories: 48% at 24 h, 4.1% at 30 h, 8.5% at 36 h, and 37.1% at 48 h. As compared to literature guidelines, the rates of overdose and underdose in gentamicin (1.5% and 2.7%) and amikacin (0.3% and 1.0%). They significantly decreased for gentamicin over the study period. In multivariate analysis, the factors significantly associated with GENT overdose were the year of admission, prematurity, length of stay, and duration of the treatment. Conclusion: This prescription strategy ensured a low rate of overdose and underdose, and some benefits of the benchmarking program is suggested. |
format | Online Article Text |
id | pubmed-8614949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86149492021-11-26 Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units Martin-Mons, Séverine Gouyon, Béatrice Lorrain, Séverine Abasse, Soumeth Alexandre, Cénéric Binson, Guillaume Brat, Roselyne Caeymaex, Laurence Couringa, Yvan Desbruyeres, Cécile Meglio, Marine Dorsi-Di Escourrou, Guillaume Flamein, Florence Flechelles, Olivier Girard, Olivier Kermorvant-Duchemin, Elsa Lapillonne, Alexandre Lafon, Catherine Di Maio, Massimo Mazeiras, Gaël Mourdie, Julien Moussy-Durandy, Amélie Pages, Anne-Sophie Ramful, Duksha Razafimahefa, Hasinirina Rosenthal, Jean-Marc Iacobelli, Silvia Gouyon, Jean-Bernard Antibiotics (Basel) Article Background: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to antibiotics in the NICU is highly desirable, particularly through benchmarking methods. Methods: Description of aminoglycosides prescriptions in 23 French NICU using the same computerized system over a 4-year period (2017–2020). A benchmarking program of antibiotics prescription was associated. Results: The population included 53,818 patients. Exposition rates to gentamicin and amikacin were 31.7% (n = 17,049) and 9.1% (n = 4894), respectively. Among neonates exposed to gentamicin, 90.4% of gentamicin and 77.6% of amikacin treatments were started within the 1st week of life. Among neonates exposed to amikacin, 77.6% started amikacin within the 1st week. The average daily dose of gentamicin at first prescription increased over the study period from 3.9 in 2017 to 4.4 mg/kg/d in 2020 (p < 0.0001). Conversely, the corresponding amikacin daily doses decreased from 13.0 in 2017 to 12.3 mg/kg/d in 2020 (p = 0.001). The time interval between the first 2 doses of gentamicin was mainly distributed in 3 values during the first week of life: 49.4% at 24 h, 26.4% at 36 h, and 22.9% at 48 h. At first amikacin prescription, the time interval was distributed in 4 categories: 48% at 24 h, 4.1% at 30 h, 8.5% at 36 h, and 37.1% at 48 h. As compared to literature guidelines, the rates of overdose and underdose in gentamicin (1.5% and 2.7%) and amikacin (0.3% and 1.0%). They significantly decreased for gentamicin over the study period. In multivariate analysis, the factors significantly associated with GENT overdose were the year of admission, prematurity, length of stay, and duration of the treatment. Conclusion: This prescription strategy ensured a low rate of overdose and underdose, and some benefits of the benchmarking program is suggested. MDPI 2021-11-20 /pmc/articles/PMC8614949/ /pubmed/34827360 http://dx.doi.org/10.3390/antibiotics10111422 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martin-Mons, Séverine Gouyon, Béatrice Lorrain, Séverine Abasse, Soumeth Alexandre, Cénéric Binson, Guillaume Brat, Roselyne Caeymaex, Laurence Couringa, Yvan Desbruyeres, Cécile Meglio, Marine Dorsi-Di Escourrou, Guillaume Flamein, Florence Flechelles, Olivier Girard, Olivier Kermorvant-Duchemin, Elsa Lapillonne, Alexandre Lafon, Catherine Di Maio, Massimo Mazeiras, Gaël Mourdie, Julien Moussy-Durandy, Amélie Pages, Anne-Sophie Ramful, Duksha Razafimahefa, Hasinirina Rosenthal, Jean-Marc Iacobelli, Silvia Gouyon, Jean-Bernard Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
title | Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
title_full | Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
title_fullStr | Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
title_full_unstemmed | Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
title_short | Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
title_sort | prescription of aminoglycosides in 23 french neonatal intensive care units |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614949/ https://www.ncbi.nlm.nih.gov/pubmed/34827360 http://dx.doi.org/10.3390/antibiotics10111422 |
work_keys_str_mv | AT martinmonsseverine prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT gouyonbeatrice prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT lorrainseverine prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT abassesoumeth prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT alexandreceneric prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT binsonguillaume prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT bratroselyne prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT caeymaexlaurence prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT couringayvan prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT desbruyerescecile prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT megliomarinedorsidi prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT escourrouguillaume prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT flameinflorence prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT flechellesolivier prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT girardolivier prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT kermorvantducheminelsa prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT lapillonnealexandre prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT lafoncatherine prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT dimaiomassimo prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT mazeirasgael prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT mourdiejulien prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT moussydurandyamelie prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT pagesannesophie prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT ramfulduksha prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT razafimahefahasinirina prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT rosenthaljeanmarc prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT iacobellisilvia prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT gouyonjeanbernard prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits |